(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.08%) $79.06
(5.02%) $2.03
(0.10%) $2 313.40
(0.68%) $26.93
(0.85%) $963.00
(-0.07%) $0.932
(-0.36%) $10.99
(-0.06%) $0.798
(-2.29%) $91.12
Live Chart Being Loaded With Signals
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States...
Stats | |
---|---|
Today's Volume | 150.70M |
Average Volume | 3.09M |
Market Cap | 172.27M |
EPS | $0 ( 2024-05-01 ) |
Next earnings date | ( $-3.65 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.220 |
ATR14 | $0.0310 (0.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-07 | Glessner Coleen | Sell | 585 | Common Stock |
2024-04-07 | Hartzel William | Sell | 665 | Common Stock |
2024-03-13 | Papa Joseph C | Buy | 750 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Williams Paul Anthony | Buy | 125 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Glessner Coleen | Buy | 125 000 | Employee Stock Options (Right to Buy) |
INSIDER POWER |
---|
95.70 |
Last 100 transactions |
Buy: 2 920 145 | Sell: 69 613 |
Volume Correlation
Emergent BioSolutions Inc Correlation
10 Most Positive Correlations | |
---|---|
ZVIA | 0.855 |
EHC | 0.845 |
CRT | 0.841 |
TJX | 0.832 |
E | 0.829 |
ACI | 0.828 |
CORN | 0.828 |
CWAN | 0.828 |
MVO | 0.827 |
CVEO | 0.826 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Emergent BioSolutions Inc Correlation - Currency/Commodity
Emergent BioSolutions Inc Financials
Annual | 2023 |
Revenue: | $1.05B |
Gross Profit: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2023 |
Revenue: | $1.05B |
Gross Profit: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2022 |
Revenue: | $1.12B |
Gross Profit: | $427.20M (38.11 %) |
EPS: | $-4.47 |
FY | 2021 |
Revenue: | $1.79B |
Gross Profit: | $1.04B (57.75 %) |
EPS: | $4.32 |
Financial Reports:
No articles found.
Emergent BioSolutions Inc
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators